“Therapeutic Approach with PCSK9 Inhibitors for Effective Cardiovascular Risk Reduction in Diabetes”, ccm, vol. 4, no. 6, pp. 736–742, Dec. 2020, Accessed: Sep. 18, 2026. Available: https://fortunejournals.org/ojs/index.php/ccm/article/view/15983